Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors

被引:64
作者
Cook, Deborah [1 ,2 ]
Douketis, James [1 ,2 ]
Meade, Maureen [1 ,2 ]
Guyatt, Gordon [1 ,2 ]
Zytaruk, Nicole [2 ]
Granton, John [3 ,4 ]
Skrobik, Yoanna [5 ,6 ]
Albert, Martin [5 ,6 ]
Fowler, Robert [3 ,4 ]
Hebert, Paul [7 ]
Pagliarello, Guiseppe [7 ]
Friedrich, Jan [3 ,4 ]
Freitag, Andreas [1 ]
Karachi, Tim [1 ]
Rabbat, Christian [1 ]
Heels-Ansdell, Diane [2 ]
Geerts, William [3 ]
Crowther, Mark [1 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada
[4] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON M5G 2C4, Canada
[5] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada
[6] Univ Montreal, Dept Crit Care, Montreal, PQ H3T 1J4, Canada
[7] Univ Ottawa, Dept Crit Care, Ottawa, ON K1H 8L6, Canada
来源
CRITICAL CARE | 2008年 / 12卷 / 02期
关键词
D O I
10.1186/cc6810
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Critically ill patients with renal insufficiency are predisposed to both deep vein thrombosis (DVT) and bleeding. The objective of the present study was to evaluate the prevalence, incidence and predictors of DVT and the incidence of bleeding in intensive care unit (ICU) patients with estimated creatinine clearance <30 ml/min. Methods In a multicenter, open-label, prospective cohort study of critically ill patients with severe acute or chronic renal insufficiency or dialysis receiving subcutaneous dalteparin 5,000 IU once daily, we estimated the prevalence of proximal DVT by screening compression venous ultrasound of the lower limbs within 48 hours of ICU admission. DVT incidence was assessed on twice-weekly ultrasound testing. We estimated the incidence of major and minor bleeding by daily clinical assessments. We used Cox proportional hazards regression to identify independent predictors of both DVT and major bleeding. Results Of 156 patients with a mean (standard deviation) creatinine clearance of 18.9 (6.5) ml/min, 18 had DVT or pulmonary embolism within 48 hours of ICU admission, died or were discharged before ultrasound testing - leaving 138 evaluable patients who received at least one dose of dalteparin. The median duration of dalteparin administration was 7 days (interquartile range, 4 to 12 days). DVT developed in seven patients (5.1%; 95% confidence interval, 2.5 to 10.1). The only independent risk factor for DVT was an elevated baseline Acute Physiology and Chronic Health Evaluation II score (hazard ratio for 10-point increase, 2.25; 95% confidence interval, 1.03 to 4.91). Major bleeding developed in 10 patients (7.2%; 95% confidence interval, 4.0 to 12.8), all with trough anti-activated factor X levels <= 0.18 IU/ml. Independent risk factors for major bleeding were aspirin use (hazard ratio, 6.30; 95% confidence interval, 1.35 to 29.4) and a high International Normalized Ratio (hazard ratio for 0.5-unit increase, 1.68; 95% confidence interval, 1.07 to 2.66). Conclusion In ICU patients with renal insufficiency, the incidence of DVT and major bleeding are considerable but appear related to patient comorbidities rather than to an inadequate or excessive anticoagulant from thromboprophylaxis with dalteparin. Clinical Trial Registration Number NCT00138099.
引用
收藏
页数:9
相关论文
共 30 条
  • [1] Arnold DM, 2007, CLIN INVEST MED, V30, pE93
  • [2] Deep vein thrombosis and its prevention in critically ill adults
    Attia, J
    Ray, JG
    Cook, DJ
    Douketis, J
    Ginsberg, JS
    Geerts, WH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (10) : 1268 - 1279
  • [3] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [4] Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors
    Cook, D
    Crowther, M
    Meade, M
    Rabbat, C
    Griffith, L
    Schiff, D
    Geerts, W
    Guyatt, G
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (07) : 1565 - 1571
  • [5] Prophylaxis of Thromboembolism in Critical Care (PROTECT)Trial:: a pilot study
    Cook, DJ
    Rocker, G
    Meade, M
    Guyatt, G
    Geerts, W
    Anderson, D
    Skrobik, Y
    Hebert, P
    Albert, M
    Cooper, J
    Bates, S
    Caco, C
    Finfer, S
    Fowler, R
    Freitag, A
    Granton, J
    Jones, G
    Langevin, S
    Mehta, S
    Pagliarello, G
    Poirier, G
    Rabbat, C
    Schiff, D
    Griffith, L
    Crowther, M
    [J]. JOURNAL OF CRITICAL CARE, 2005, 20 (04) : 364 - 372
  • [6] COOK DJ, 2003, CRIT CARE MED, pA346
  • [7] PREVALENCE OF DEEP VENOUS THROMBOSIS AMONG PATIENTS IN MEDICAL INTENSIVE GALE
    HIRSCH, DR
    INGENITO, EP
    GOLDHABER, SZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (04): : 335 - 337
  • [8] Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
    Hirsh, J
    Warkentin, TE
    Shaughnessy, SG
    Anand, SS
    Halperin, JL
    Raschke, R
    Granger, C
    Ohman, EM
    Dalen, JE
    [J]. CHEST, 2001, 119 (01) : 64S - 94S
  • [9] Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis
    Ibrahim, EH
    Iregui, M
    Prentice, D
    Sherman, G
    Kollef, MH
    Shannon, W
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (04) : 771 - 774
  • [10] Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype
    Irish, AB
    Green, FR
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (03) : 679 - 684